Â¥
31.49
May 7
Business Description
Shenzhen Salubris Pharmaceuticals Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE100000FW8
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 51.71 | |||||
Equity-to-Asset | 0.86 | |||||
Debt-to-EBITDA | 0.05 | |||||
Interest Coverage | 37.85 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 17.53 | |||||
Beneish M-Score | -2.43 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.8 | |||||
3-Year EBITDA Growth Rate | 41.8 | |||||
3-Year EPS without NRI Growth Rate | 389.8 | |||||
3-Year FCF Growth Rate | -40.6 | |||||
3-Year Book Growth Rate | 11 | |||||
Future 3-5Y Total Revenue Growth Rate | 17.33 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 63.19 | |||||
9-Day RSI | 64.21 | |||||
14-Day RSI | 62.2 | |||||
6-1 Month Momentum % | -11.79 | |||||
12-1 Month Momentum % | -18.98 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.32 | |||||
Quick Ratio | 3.75 | |||||
Cash Ratio | 1.97 | |||||
Days Inventory | 160.11 | |||||
Days Sales Outstanding | 52.52 | |||||
Days Payable | 51.83 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.59 | |||||
Dividend Payout Ratio | 0.91 | |||||
Forward Dividend Yield % | 1.59 | |||||
5-Year Yield-on-Cost % | 1.6 | |||||
3-Year Average Share Buyback Ratio | -2.1 | |||||
Shareholder Yield % | 1.71 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 68.87 | |||||
Operating Margin % | 18.05 | |||||
Net Margin % | 15.95 | |||||
FCF Margin % | 7.33 | |||||
ROE % | 7.1 | |||||
ROA % | 5.98 | |||||
ROIC % | 8.58 | |||||
ROC (Joel Greenblatt) % | 28.77 | |||||
ROCE % | 7.6 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 61.75 | |||||
PE Ratio without NRI | 57.05 | |||||
Shiller PE Ratio | 33.86 | |||||
Price-to-Owner-Earnings | 499.84 | |||||
PS Ratio | 9.83 | |||||
PB Ratio | 4.27 | |||||
Price-to-Tangible-Book | 6.31 | |||||
Price-to-Free-Cash-Flow | 136.9 | |||||
Price-to-Operating-Cash-Flow | 37.26 | |||||
EV-to-EBIT | 51.56 | |||||
EV-to-Forward-EBIT | 35.22 | |||||
EV-to-EBITDA | 51.56 | |||||
EV-to-Forward-EBITDA | 29.4 | |||||
EV-to-Revenue | 9.35 | |||||
EV-to-Forward-Revenue | 6.56 | |||||
EV-to-FCF | 130 | |||||
Price-to-Projected-FCF | 2.72 | |||||
Price-to-Median-PS-Value | 1.12 | |||||
Price-to-Graham-Number | 4 | |||||
Price-to-Net-Current-Asset-Value | 16.57 | |||||
Price-to-Net-Cash | 165.74 | |||||
Earnings Yield (Greenblatt) % | 1.94 | |||||
FCF Yield % | 0.75 | |||||
Forward Rate of Return (Yacktman) % | -0.14 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Shenzhen Salubris Pharmaceuticals Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 3,568.8 | ||
EPS (TTM) (Â¥) | 0.51 | ||
Beta | 1.21 | ||
Volatility % | 35.64 | ||
14-Day RSI | 62.2 | ||
14-Day ATR (Â¥) | 0.922165 | ||
20-Day SMA (Â¥) | 29.7305 | ||
12-1 Month Momentum % | -18.98 | ||
52-Week Range (Â¥) | 23.5 - 36.43 | ||
Shares Outstanding (Mil) | 1,114.82 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Shenzhen Salubris Pharmaceuticals Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Shenzhen Salubris Pharmaceuticals Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Shenzhen Salubris Pharmaceuticals Co Ltd Frequently Asked Questions
What is Shenzhen Salubris Pharmaceuticals Co Ltd(SZSE:002294)'s stock price today?
When is next earnings date of Shenzhen Salubris Pharmaceuticals Co Ltd(SZSE:002294)?
Does Shenzhen Salubris Pharmaceuticals Co Ltd(SZSE:002294) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |